Susquehanna International Group’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6K | Buy |
74,823
+41,110
| +122% | +$16.3K | ﹤0.01% | 6112 |
|
|
2025
Q1 | $11.7K | Sell |
33,713
-180,518
| -84% | -$62.6K | ﹤0.01% | 6210 |
|
|
2024
Q4 | $127K | Buy |
214,231
+34,505
| +19% | +$20.4K | ﹤0.01% | 5571 |
|
|
2024
Q3 | $316K | Buy |
179,726
+10,263
| +6% | +$18.1K | ﹤0.01% | 4231 |
|
|
2024
Q2 | $232K | Buy |
169,463
+80,280
| +90% | +$110K | ﹤0.01% | 4540 |
|
|
2024
Q1 | $307K | Buy |
89,183
+29,854
| +50% | +$103K | ﹤0.01% | 4154 |
|
|
2023
Q4 | $146K | Sell |
59,329
-66,917
| -53% | -$165K | ﹤0.01% | 5174 |
|
|
2023
Q3 | $215K | Buy |
126,246
+10,579
| +9% | +$18K | ﹤0.01% | 4468 |
|
|
2023
Q2 | $347K | Sell |
115,667
-141,298
| -55% | -$424K | ﹤0.01% | 4069 |
|
|
2023
Q1 | $689K | Buy |
256,965
+29,240
| +13% | +$78.4K | ﹤0.01% | 3396 |
|
|
2022
Q4 | $1.88M | Buy |
227,725
+156,263
| +219% | +$1.29M | ﹤0.01% | 1645 |
|
|
2022
Q3 | $550K | Sell |
71,462
-50,509
| -41% | -$389K | ﹤0.01% | 3402 |
|
|
2022
Q2 | $348K | Buy |
121,971
+17,676
| +17% | +$50.4K | ﹤0.01% | 3798 |
|
|
2022
Q1 | $521K | Buy |
104,295
+74,884
| +255% | +$374K | ﹤0.01% | 3661 |
|
|
2021
Q4 | $577K | Buy |
29,411
+4,716
| +19% | +$92.5K | ﹤0.01% | 3592 |
|
|
2021
Q3 | $727K | Buy |
24,695
+15,966
| +183% | +$470K | ﹤0.01% | 3191 |
|
|
2021
Q2 | $370K | Buy |
+8,729
| New | +$370K | ﹤0.01% | 4242 |
|